Sequoia Capital the is the largest shareholder of Chinese credit platform Jianpu Technology (JT), which begins trading on the NYSE on Thursday. The ...read more
AutoGenomics, which sells a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its plans for an initial public offering on Monday. It had first filed to go public in 2008 but withdrew its plans in 2011. It then set terms in...read more
Natera, which sells non-invasive prenatal disease screening tests, raised $180 million by offering 10.0 million shares at $18, the high end of the range of $17 to $18. Natera previously filed to raise $100 million by offering 6.3 million shares at $15-$17....read more
Natera, which sells non-invasive prenatal disease screening tests, raised the proposed deal size for its upcoming IPO on Wednesday. The San Carlos, CA-based company now plans to raise $175 million by offering 10 million shares at a price range of $17 to $18. The...read more
Venture Capital-backed IPOs: A look at Sequoia Capital
Sequoia Capital the is the largest shareholder of Chinese credit platform Jianpu Technology (JT), which begins trading on the NYSE on Thursday. The ...read more
Genetic tests in a jam: AutoGenomics withdraws third IPO attempt
AutoGenomics, which sells a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its plans for an initial public offering on Monday. It had first filed to go public in 2008 but withdrew its plans in 2011. It then set terms in...read more
Natera prices IPO at $18, the high end of the revised range
Natera, which sells non-invasive prenatal disease screening tests, raised $180 million by offering 10.0 million shares at $18, the high end of the range of $17 to $18. Natera previously filed to raise $100 million by offering 6.3 million shares at $15-$17....read more
Natera increases proposed IPO deal size by 75%
Natera, which sells non-invasive prenatal disease screening tests, raised the proposed deal size for its upcoming IPO on Wednesday. The San Carlos, CA-based company now plans to raise $175 million by offering 10 million shares at a price range of $17 to $18. The...read more